Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

Journal Article · · Nature Medicine
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [2];  [2];  [2];  [3];  [4];  [5];  [5];  [6];  [7];  [8];  [9];  [9];  [9] more »;  [10];  [10];  [11];  [12];  [13];  [14];  [1];  [1];  [1];  [15];  [1];  [1];  [1] « less
  1. Emory Univ. School of Medicine, Atlanta, GA (United States)
  2. Johns Hopkins School of Medicine, Baltimore, MD (United States)
  3. National Institutes of Health (NIH), Bethesda, MD (United States)
  4. Stanford Univ., CA (United States)
  5. Univ. of Pennsylvania, Philadelphia, PA (United States). Perelman School of Medicine
  6. Banner Sun Health Research Institute, Sun City, AZ (United States)
  7. Arizona State Univ., Phoenix, AZ (United States); Univ. of Arizona, Phoenix, AZ (United States)
  8. Icahn School of Medicine at Mount Sinai, New York, NY (United States); JJ Peters VA Medical Center MIRECC, Bronx, NY (United States)
  9. Icahn School of Medicine at Mount Sinai, New York, NY (United States)
  10. Mayo Clinic, Jacksonville, FL (United States)
  11. Univ. of Florida, Gainesville, FL (United States)
  12. Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
  13. Columbia University Irving Medical Center, New York, NY (United States)
  14. Rush University Medical Center, Chicago, IL (United States)
  15. Baylor College of Medicine, Houston, TX (United States); Texas Children’s Hospital, Houston, TX (United States)
Our understanding of Alzheimer’s disease (AD) pathophysiology remains incomplete. Here, for this work, we used quantitative mass spectrometry and coexpression network analysis to conduct the largest proteomic study thus far on AD. A protein network module linked to sugar metabolism emerged as one of the modules most significantly associated with AD pathology and cognitive impairment. This module was enriched in AD genetic risk factors and in microglia and astrocyte protein markers associated with an anti-inflammatory state, suggesting that the biological functions it represents serve a protective role in AD. Proteins from this module were elevated in cerebrospinal fluid in early stages of the disease. In this study of >2,000 brains and nearly 400 cerebrospinal fluid samples by quantitative proteomics, we identify proteins and biological processes in AD brains that may serve as therapeutic targets and fluid biomarkers for the disease.
Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE
Grant/Contract Number:
AC05-76RL01830
OSTI ID:
1995091
Report Number(s):
PNNL-SA-156646
Journal Information:
Nature Medicine, Journal Name: Nature Medicine Journal Issue: 5 Vol. 26; ISSN 1078-8956
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English

References (67)

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects journal April 2009
Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease journal January 2019
Neuropathological stageing of Alzheimer-related changes journal September 1991
Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer’s disease pathology journal April 2008
Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease journal March 2017
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model journal March 2015
A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease journal January 2017
Asymmetric dimethylarginine exacerbates Aβ-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease journal February 2015
Quantitative Proteomics Reveals Subset-Specific Viral Recognition in Dendritic Cells journal February 2010
Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes journal January 2019
Metabolic network failures in Alzheimer's disease: A biochemical road map journal March 2017
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease journal April 2018
Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction journal December 2014
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression journal March 2020
Mapping protein abundance patterns in the brain using voxelation combined with liquid chromatography and mass spectrometry journal February 2010
Boosting to Amplify Signal with Isobaric Labeling (BASIL) Strategy for Comprehensive Quantitative Phosphoproteomic Characterization of Small Populations of Cells journal March 2019
Integrating Next-Generation Genomic Sequencing and Mass Spectrometry To Estimate Allele-Specific Protein Abundance in Human Brain journal August 2017
Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood–Brain Barrier Permeability in Older Adults journal January 2019
Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics journal November 2014
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 journal July 2006
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 journal July 2006
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease journal October 2013
MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics journal October 2011
Functional organization of the transcriptome in human brain journal October 2008
Identification of a unique TGF-β–dependent molecular and functional signature in microglia journal December 2013
Network medicine: a network-based approach to human disease journal December 2010
Microglia in neurodegeneration journal September 2018
Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry journal July 2018
Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease journal March 2018
Review journal April 1998
Variant of TREM2 Associated with the Risk of Alzheimer's Disease journal January 2013
DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 journal October 2006
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ journal June 2014
Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics journal August 2012
How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond? journal October 2015
GWAS of longitudinal amyloid accumulation on 18 F-florbetapir PET in Alzheimer’s disease implicates microglial activation gene IL1RAP journal August 2015
Early and protective microglial activation in Alzheimer’s disease: a prospective study using18F-DPA-714 PET imaging journal March 2016
Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis journal June 2013
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program: Arizona Brain and Body Donation Program journal January 2015
Microglial Physiology: Unique Stimuli, Specialized Responses journal April 2009
The Rush Memory and Aging Project: Study Design and Baseline Characteristics of the Study Cohort journal January 2005
A Systems Biology Framework Identifies Molecular Underpinnings of Coronary Heart Disease journal June 2013
Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease journal November 2017
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease journal May 2018
Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease journal October 2018
Alzheimer disease pathology and the cerebrospinal fluid proteome journal July 2018
Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis journal May 2015
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers journal July 2016
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease journal April 1991
Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF journal May 1999
Is My Network Module Preserved and Reproducible? journal January 2011
MAGMA: Generalized Gene-Set Analysis of GWAS Data journal April 2015
Automated Network Analysis Identifies Core Pathways in Glioblastoma journal February 2010
A Reduced Astrocyte Response to β-Amyloid Plaques in the Ageing Brain Associates with Cognitive Impairment journal February 2015
A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging journal February 2008
Genomic Analysis of Reactive Astrogliosis journal May 2012
A proteomic network approach across the ALS ‐ FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain journal November 2017
Integrative network analysis reveals molecular mechanisms of blood pressure regulation journal April 2015
Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis journal March 2017
Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis journal June 2017
Overview and Findings from the Religious Orders Study journal June 2012
Overview and Findings from the Rush Memory and Aging Project journal June 2012
Religious Orders Study and Rush Memory and Aging Project journal June 2018
Neuropathologic Studies of the Baltimore Longitudinal Study of Aging (BLSA) journal October 2009
Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease collection January 2017
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease collection January 2018
Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease collection January 2018

Cited By (26)

Additional file 2 of Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury image January 2021
Additional file 3 of Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury image January 2021
Additional file 1 of Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers dataset January 2022
Additional file 3 of Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers image January 2022
Additional file 4 of Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers image January 2022
Additional file 1 of Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity dataset January 2022
Additional file 2 of Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity dataset January 2022
Additional file 3 of Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity dataset January 2022
Additional file 3 of Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease dataset January 2023
Additional file 4 of Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease dataset January 2023
Additional file 5 of Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease dataset January 2023
Additional file 6 of Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease dataset January 2023
Additional file 7 of Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease dataset January 2023
Additional file 8 of Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease dataset January 2023
Additional file 9 of Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease dataset January 2023
Additional file 10 of Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease dataset January 2023
Additional file 3 of A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease dataset January 2023
Additional file 2 of Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics dataset January 2023
Additional file 3 of Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics dataset January 2023
Additional file 4 of Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics dataset January 2023
Additional file 5 of Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics dataset January 2023
Additional file 6 of Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics dataset January 2023
Additional file 7 of Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics dataset January 2023
Additional file 8 of Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics dataset January 2023
Additional file 1 of The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus dataset January 2023
Additional file 2 of The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus dataset January 2023

Similar Records

BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology
Journal Article · Wed Jul 29 00:00:00 EDT 2020 · Molecular Neurodegeneration · OSTI ID:1668667

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement
Journal Article · Sun Dec 04 23:00:00 EST 2016 · Alzheimer's & Dementia · OSTI ID:1393230

Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia
Journal Article · Mon Jul 02 20:00:00 EDT 2018 · Annals of Neurology · OSTI ID:1458778